Cronos Group
Men hold 93% of Canadian cannabis boardroom positions
Two dozen of the leading cannabis companies in Canada collectively employ only 11 women on their boards, and most – including the market leaders – have not disclosed written policies relating to the identification and nomination of female directors.
Canadian medical cannabis exports tripled last year, as race for European market position intensifies
Exports of medical cannabis from Canada soared last year as the country’s biggest licensed cannabis companies continued to establish beachheads in new medical markets overseas.
Amyris closes on potential $300M cannabinoid deal with biotech firm
Amyris, a California-based company focused on wellness products, said it has closed a deal potentially worth $300 million with biotech startup Lavvan to research and develop synthetic cannabinoids.
Weekly Deal Watch: Cannabis capital raises outpace record 2018 levels
North American cannabis companies have raised nearly $3.3 billion so far this year, outpacing the record funding levels set in 2018, according to the latest data from Viridian Capital Advisors.
Billionaire Peltz joins Aurora Cannabis to advise on partnerships, expansion
Nelson Peltz will join Aurora Cannabis as a strategic adviser to help the company lock in partnerships and expand internationally – a move seen as a major vote of confidence for the Canadian company and broader marijuana industry.